Curetic Biotechs Private Limited - Due diligence report

A 360° intelligence report on Curetic Biotechs Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2014-12-01 Pune, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
CB Curetic Biotechs Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Curetic Biotechs Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
63/100
Trust Score
Moderate

Curetic Biotechs Private Limited is assessed as Moderate with a Trust Score of 63/100. Curetic Biotechs Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 16 Aug 2026 from the latest processed filings. Curetic Biotechs Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
63/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
15/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Working-capital cover adequate.

Charges position: 2 open (6.25 cr) · 1 satisfied (1.50 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SOHAN LATA JHA 01234567 Director 01/04/2018 6 yrs Approved
RAJU SHIVSHANKAR JHA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2019)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 4 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 30
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Operating for 11+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 1.42 in a year.
Negative net worth.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence63/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment47/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 6.25 cr already registered.
  • Compliance record supports lending.
Investor view49/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
08 Aug 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Mar 2024
Director appointed
RAJU SHIVSHANKAR JHA (Director)
Director ceased
DEEPAK KUMAR SHUKLA
31 Mar 2023
Charge created
Others - 1.25 cr
25 Nov 2021
Charge satisfied
Others
22 Nov 2021
Charge created
Others - 5.00 cr
25 Jun 2020
Charge created
Others - 1.50 cr
31 Mar 2019
Share transfer (FY 2019)
5000.00000000 shares to SOHANLATA RAJU JHA
Share transfer (FY 2019)
2990.00000000 shares to RAJESH GADIYA
Share transfer (FY 2019)
1000.00000000 shares to DEEPAK SHUKLA
22 Jun 2018
Director ceased
SHRIRANGAM SOMAIAH
31 Mar 2018
Share transfer (FY 2018)
1000.00000000 shares to SOHANLATA RAJU JHA
22 Mar 2018
Director ceased
PRAKASH KUMAR SATYENDRA NARAYAN SINGH
17 Aug 2016
Director ceased
GANESH VISHWASRAO CHINTAWAR
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Icons Futuretech Private Limited U52599MH2020PTC351739 Mumbai, Maharashtra, India
Kayel Medichem Private Limited U74900DL2009PTC188843 New Delhi, Delhi, India
Lagom Retail Private Limited U74999DL2018PTC341050 Delhi, Delhi, India
Jaasodha Auto Private Limited U50403DL2003PTC122736 Delhi, Delhi, India
Dhuliyan Diagnostic & Health Care Private Limited U85100WB2012PTC189118 Dhuliyan, West Bengal, India
Imperial Wheels Private Limited U74110BR2017PTC033948 Patna, Bihar, India
Prathamik Knitwear Private Limited U17299GJ2021PTC119772 Surat, Gujarat, India
Ds Luxury Retail Limited U47710DL2011PLC216226 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Curetic Biotechs Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Curetic Biotechs Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Curetic Biotechs Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 63/100, distress signals and MSME payment-delay disclosures - know whether Curetic Biotechs Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Curetic Biotechs Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Curetic Biotechs Private Limited an active company?

Curetic Biotechs Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Curetic Biotechs Private Limited financially healthy?

Curetic Biotechs Private Limited has a Financial Health Score of 15/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Curetic Biotechs Private Limited?

Its overall Trust Score is 63/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Curetic Biotechs Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Curetic Biotechs Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Curetic Biotechs Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Curetic Biotechs Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.